EN
登录

症状性子宫肌瘤子宫动脉栓塞与肌瘤切除术的系统评价和荟萃分析

Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids

Nature 等信源发布 2024-08-20 20:37

可切换为仅中文


AbstractThis review compares the efficacy of Uterine Artery Embolization (UAE) and Myomectomy (MYO) in managing symptomatic Uterine Fibroids (UFs) in women who do not want hysterectomy. A meta-analysis was performed on all available studies that evaluated the relative benefits and harms of MYO and UEA for the management of patients suffering from UFs.

摘要本综述比较了子宫动脉栓塞(UAE)和子宫肌瘤切除术(MYO)在不希望子宫切除术的女性中治疗症状性子宫肌瘤(UF)的疗效。对所有可用的研究进行了荟萃分析,评估了MYO和UEA对UFs患者管理的相对益处和危害。

Outcomes evaluated reintervention, UFs scores for quality of life (QOL) and symptom severity, and other complications. To determine mean differences (MDs) or odds ratios (ORs) with 95% confidence intervals (CIs), a random or fixed-effects model was utilized. A meta-analysis of 13 studies (9 observational and 4 randomized controlled trials) was conducted.

结果评估了再次干预,UFs评分的生活质量(QOL)和症状严重程度以及其他并发症。为了确定95%置信区间(CI)的平均差异(MD)或优势比(or),使用了随机或固定效应模型。对13项研究(9项观察性试验和4项随机对照试验)进行了荟萃分析。

The results indicated that UAE had a higher reintervention rate (OR 1.84; 95% CI 1.62–2.10; P < 0.01; I2 = 39%), hysterectomy rate (OR 4.04; 95% CI 3.45–4.72; P < 0.01; I2 = 59%), and symptom-severity score (OR − 4.02; 95% CI 0.82, 7.22; P = 0.01; I2 = 0%) compared to MYO at a four-year follow-up. However, UAE was associated with a lower rate of early complications (OR 0.44; 95% CI 0.20–0.95; P = 0.04; I2 = 25%), and readmission rate (OR 1.16; 95% CI 1.01–1.33; P = 0.04; I2 = 0%) compared to MYO.

结果表明,阿联酋的再干预率较高(OR 1.84;95%CI 1.62-2.10;P<0.01;I2=39%),子宫切除率(OR 4.04;95%CI 3.45-4.72;P<0.01;I2=59%)和症状严重程度评分(OR=4.02);;P=0.01;在四年的随访中,I2=0%)与MYO相比。然而,阿联酋早期并发症发生率较低(OR 0.44;95%CI 0.20-0.95;P=0.04;I2=25%)和再入院率(OR 1.16;95%CI 1.01-1.33;P=0.04;I2=0%)与MYO相比。

Furthermore, both procedures had comparable improvement in pregnancy rates and abnormal uterine bleeding. In conclusion, UAE and MYO are effective in treating symptomatic UFs but they have different outcomes. The decision on which procedure to choose should be made based on individual preferences and the physician’s expertise..

。总之,阿联酋和MYO在治疗症状性UFs方面是有效的,但它们有不同的结果。应根据个人偏好和医生的专业知识决定选择哪种手术。。

IntroductionUterine fibroids, also known as myomas, are the most common benign tumors affecting women during their reproductive years, with prevalence increasing with age1,2. Symptoms of fibroids, such as heavy menstrual bleeding, abdominal pain, and pressure3, can have a negative impact on quality of life4,5.

引言子宫肌瘤,也称为肌瘤,是影响女性生殖期最常见的良性肿瘤,患病率随着年龄的增长而增加1,2。肌瘤的症状,如月经大量出血,腹痛和压力3,可能会对生活质量产生负面影响4,5。

Surgical treatments such as hysterectomy and myomectomy (MYO) remain the conventional choices for managing fibroids. However, a minimally invasive treatment, uterine artery embolization (UAE), has emerged as an alternative to hysterectomy, which has been in practice since 19956. UAE is now often used as an elective treatment for symptomatic UFs due to its safety and ability to improve symptoms with few major complications7.

子宫切除术和子宫肌瘤切除术(MYO)等手术治疗仍然是治疗肌瘤的常规选择。然而,一种微创治疗方法,子宫动脉栓塞(UAE)已成为子宫切除术的替代方法,自19956年以来一直在实践中。阿联酋现在经常被用作症状性UFs的选择性治疗,因为它的安全性和改善症状的能力几乎没有重大并发症7。

For those who desire to preserve their uterus, MYO is typically the standard of care, but there is uncertainty regarding the optimal treatment choice. Therefore, this paper aimed to systematically review and meta-analyze all relevant studies to compare the outcomes of UAE and MYO treatments for the management of uterine fibroids.MethodsThis meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement8, involves two independent investigators undertaking the literature search, selection, and data extraction in duplicate, ensuring the integrity of the research process.

对于那些希望保留子宫的人来说,MYO通常是护理的标准,但最佳治疗选择存在不确定性。因此,本文旨在系统地回顾和荟萃分析所有相关研究,以比较UAE和MYO治疗子宫肌瘤的结果。方法该荟萃分析是根据系统评价和荟萃分析的首选报告项目(PRISMA)声明8进行的,涉及两名独立研究人员,一式两份进行文献检索,选择和数据提取,确保研究过程的完整性。

In the event of any discrepancy arising between these investigators, a third investigator was consulted to resolve any differences by reaching consensus, underscoring the rigorous quality control measures implemented in this study.Search strategyRelevant studies, before November 2023, were identified by searching PubMed, Embase, Medline, and the Cochrane Library for English-language studies related to uterin.

如果这些研究人员之间出现任何差异,则咨询第三位研究人员,通过达成共识来解决任何差异,强调本研究中实施的严格质量控制措施。2023年11月之前的搜索策略相关研究是通过搜索PubMed,Embase,Medline和Cochrane图书馆中与子宫素相关的英语研究来确定的。

Data availability

数据可用性

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

本研究中使用和/或分析的数据集可根据合理要求从通讯作者处获得。

ReferencesStewart, E. A. et al. Epidemiology of uterine fibroids: A systematic review. BJOG 124, 1501–1512 (2017).Article

Referencestewart,E.A.等人,《子宫肌瘤的流行病学:系统综述》。BJOG 1241501–1512(2017)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Lurie, S. et al. Age-related prevalence of sonographicaly confirmed uterine myomas. J. Obstet. Gynaecol. 25, 42–44 (2005).Article

Lurie,S.等人。超声检查证实子宫肌瘤的年龄相关患病率。J、 障碍。妇科。25,42-44(2005)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Drayer, S. M. & Catherino, W. H. Prevalence, morbidity, and current medical management of uterine leiomyomas. Int. J. Gynaecol. Obstet. 131, 117–122 (2015).Article

Drayer,S.M。和Catherino,W.H。子宫平滑肌瘤的患病率,发病率和目前的医疗管理。国际妇科杂志。障碍。131117-122(2015)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Downes, E. et al. The burden of uterine fibroids in five European countries. Eur. J. Obstet. Gynecol. Reprod. Biol. 152, 96–102 (2010).Article

Downes,E.等人,《欧洲五个国家子宫肌瘤的负担》。欧洲药典。妇科。重新编程。生物学152,96-102(2010)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Borah, B. J. et al. The impact of uterine leiomyomas: A national survey of affected women. Am. J. Obstet. Gynecol. 209(319), e1-319.e20 (2013).

Borah,B.J.等人,《子宫平滑肌瘤的影响:全国受影响女性调查》。美国J.Obstet。妇科。。

Google Scholar

谷歌学者

Ravina, J. H. et al. Arterial embolisation to treat uterine myomata. Lancet 346, 671–672 (1995).Article

Ravina,J.H.等人。动脉栓塞治疗子宫肌瘤。柳叶刀346671-672(1995)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Amoah, A. et al. Appraisal of national and international uterine fibroid management guidelines: a systematic review. BJOG 129, 356–364 (2022).Article

Amoah,A.等人,《国家和国际子宫肌瘤管理指南的评估:系统综述》。BJOG 129356-364(2022)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 8, 336–341 (2010).Article

Moher,D.,Liberati,A.,Tetzlaff,J.,Altman,D.G.,PRISMA Group。系统评价和荟萃分析的首选报告项目:PRISMA声明。《国际外科杂志》8336-341(2010)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Higham, J. M., O’Brien, P. M. & Shaw, R. W. Assessment of menstrual blood loss using a pictorial chart. Br. J. Obstet. Gynaecol. 97, 734–739 (1990).Article

Higham,J.M.,O'Brien,P.M。和Shaw,R.W。使用图表评估月经失血量。Br.J.Obstet公司。妇科。97734-739(1990)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Wells GSB, O’Connell D, Peterson J. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalyses. Available at: www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed May 1, 2022.Higgins, J. P. et al. The Cochrane collaboration’s tool for assessing risk of bias in randomized trials.

Wells GSB,O'Connell D,Peterson J.纽卡斯尔-渥太华量表(NOS),用于评估荟萃分析中非随机研究的质量。网址:www.ohri.ca/programs/clinical\u epidemiology/oxford.asp。2022年5月1日访问。Higgins,J.P。等人。Cochrane协作网评估随机试验偏倚风险的工具。

BMJ 343, 5928 (2011).Article .

BMJ 3435928(2011)。文章。

Google Scholar

谷歌学者

Ioannidis, J. P. Interpretation of tests of heterogeneity and bias in meta-analysis. J. Eval. Clin. Pract. 14, 951–957 (2008).Article

Ioannidis,J.P。荟萃分析中异质性和偏倚测试的解释。J、 评估。临床。实践。14951-957(2008)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Higgins, J. P. et al. Measuring inconsistency in meta-analyses. BMJ 327, 557–560 (2003).Article

Higgins,J.P.等人。测量荟萃分析中的不一致性。BMJ 327557-560(2003)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Rana, D. et al. Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: A cost-utility analysis of the FEMME trial. BJOG 128(11), 1793–1802 (2021).Article

Rana,D.等人。子宫动脉栓塞或子宫肌瘤切除术治疗子宫肌瘤患者希望避免子宫切除术:FEMME试验的成本效用分析。BJOG 128(11),1793-1802(2021)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Manyonda, I. et al. Uterine-artery embolization or myomectomy for uterine fibroids. N. Engl. J. Med. 383, 440–451 (2020).Article

Manyonda,I。等。子宫动脉栓塞或子宫肌瘤切除术治疗子宫肌瘤。N、 英语。J、 医学383440-451(2020)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Daniels, J. et al. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technol. Assess. 26, 1–74 (2022).PubMed

Daniels,J.等人。子宫动脉栓塞与子宫肌瘤切除术治疗绝经前子宫肌瘤希望避免子宫切除术的女性:FEMME RCT。健康技术。评估。26,1-74(2022)。PubMed出版社

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Sirkeci, F. et al. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial. Int. J. Gynaecol. Obstet. 160, 492–501 (2023).Article

Sirkeci,F.等人,《子宫动脉栓塞(UAE)或子宫肌瘤切除术对希望避免子宫切除术的子宫肌瘤患者月经大出血和妊娠的影响:FEMME随机对照试验》。国际妇科杂志。障碍。160492-501(2023)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Daniels, J. et al. Uterine artery embolization or myomectomy for women with uterine fibroids: Four-year follow-up of a randomised controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. X 13, 100139 (2021).PubMed

Daniels,J.等。子宫肌瘤患者的子宫动脉栓塞或子宫肌瘤切除术:一项随机对照试验的四年随访。欧洲药典。妇科。重新编程。生物杂志X 13100139(2021)。PubMed出版社

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Manyonda, I. T. et al. Uterine artery embolization versus myomectomy: Impact on quality of life–results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. Cardiovasc. Intervent. Radiol. 35, 530–536 (2012).Article

Manyonda,I.T.等人,《子宫动脉栓塞与子宫肌瘤切除术:对生活质量的影响——FUME(子宫肌瘤:子宫肌瘤切除术与栓塞术)试验的结果》。心血管。。放射性。35530-536(2012)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Mara, M. et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc. Intervent. Radiol. 31, 73–85 (2008).Article

一项比较子宫肌瘤栓塞和子宫肌瘤切除术的随机对照试验的中期临床和首次生殖结果。心血管。。放射性。31,73-85(2008)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Allameh, Z. et al. Evaluation of the efficacy and complications of uterine artery embolization in comparison with laparotomy-myomectomy in the treatment of uterine myomas: A randomized clinical trial. Med. J. Islam Repub. Iran 36, 87 (2022).PubMed

Allameh,Z.等。子宫动脉栓塞与开腹子宫肌瘤切除术治疗子宫肌瘤的疗效和并发症评估:一项随机临床试验。伊斯兰共和国医学杂志。伊朗36,87(2022)。PubMed出版社

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Anchan, R. M. et al. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids. Am. J. Obstet. Gynecol. 229(275), e1-275.e17 (2023).

Anchan,R.M.等人。子宫切除术、子宫肌瘤切除术或子宫动脉栓塞治疗症状性子宫肌瘤后的长期健康相关生活质量和症状严重程度。美国J.Obstet。妇科。229(275),e1-275.e17(2023)。

Google Scholar

谷歌学者

Al-Fozan, H. et al. Cost analysis of myomectomy, hysterectomy, and uterine artery embolization. Am. J. Obstet. Gynecol. 187, 1401–1404 (2002).Article

Al Fozan,H。等人。子宫肌瘤切除术、子宫切除术和子宫动脉栓塞的成本分析。美国J.Obstet。妇科。1871401-1404(2002)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Amoah, A. & Quinn, S. D. Uterine-preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: A retrospective cohort study of long-term outcomes. BJOG 130, 823–831 (2023).Article

Amoah,A.&Quinn,S.D。子宫肌瘤切除术或子宫动脉栓塞后保留子宫的治疗或子宫切除术的再次介入:一项长期结果的回顾性队列研究。BJOG 130823-831(2023)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Broder, M. S. et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet. Gynecol. 100, 864–868 (2002).PubMed

Broder,M.S.等人。子宫肌瘤切除术和子宫动脉栓塞的长期结果比较。障碍。妇科。。PubMed出版社

Google Scholar

谷歌学者

Davis, M. R. et al. Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids. J. Womens Health 27, 1204–1214 (2018).Article

Davis,M.R.等人。子宫肌瘤患者在子宫肌瘤切除术、子宫内膜消融和子宫动脉栓塞后的再干预率。J、 《女性健康》271204-1214(2018)。文章

Google Scholar

谷歌学者

Goldberg, J. et al. Cost and reimbursement for three fibroid treatments: Abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization. Cardiovasc. Intervent. Radiol. 30, 54–58 (2007).Article

Goldberg,J.等人。三种肌瘤治疗的费用和报销:腹式子宫切除术,腹式子宫肌瘤切除术和子宫肌瘤栓塞。心血管。。放射性。30,54-58(2007)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Goodwin, S. C. et al. Uterine artery embolization versus myomectomy: A multicenter comparative study. Fertil. Steril. 85, 14–21 (2006).Article

Goodwin,S.C.等人,《子宫动脉栓塞与子宫肌瘤切除术:一项多中心比较研究》。费尔蒂尔。Steril.85,14-21(2006)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Narayan, A. et al. Uterine artery embolization versus abdominal myomectomy: A long-term clinical outcome comparison. J. Vasc. Interv. Radiol. 21, 1011–1017 (2010).Article

Narayan,A。等。子宫动脉栓塞与腹部子宫肌瘤切除术:长期临床结果比较。J、 Vasc。Interv公司。放射性。211011-1017(2010)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Razavi, M. K. et al. Abdominal myomectomy versus uterine fibroid embolization in the treatment of symptomatic uterine leiomyomas. AJR Am. J. Roentgenol. 180, 1571–1575 (2003).Article

Razavi,M.K.等。腹部子宫肌瘤切除术与子宫肌瘤栓塞治疗症状性子宫平滑肌瘤的比较。AJR Am.J.Roentgenol。1801571-1575(2003)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Spies, J. B. et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet. Gynecol. 99, 290–300 (2002).PubMed

Spies,J.B.等人,《UFS-QOL》,一种新的针对平滑肌瘤的疾病特异性症状和健康相关生活质量问卷。障碍。妇科。99290-300(2002)。PubMed出版社

Google Scholar

谷歌学者

Coyne, K. S. et al. Psychometric validation of the 1-month recall uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). J. Patient Rep. Outcomes 3, 57 (2019).Article

Coyne,K.S.等人。1个月回忆子宫肌瘤症状和健康相关生活质量问卷(UFS-QOL)的心理测量学验证。J、 患者代表结果3,57(2019)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Fonseca, M. C. M. et al. uterine artery embolization and surgical methods for the treatment of symptomatic uterine leiomyomas: A systemic review and meta-analysis followed by indirect treatment comparison. Clin. Ther. 39, 1438-1455.e2 (2017).Article

Fonseca,M.C.M.等。子宫动脉栓塞和手术方法治疗症状性子宫平滑肌瘤:系统综述和荟萃分析,然后进行间接治疗比较。临床。他们。391438-1455.e2(2017)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Moss, J. G. et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 118, 936–944 (2011).Article

Moss,J.G.等人,《症状性子宫肌瘤患者子宫动脉栓塞(UAE)与手术治疗的随机比较》(REST试验):5年结果。BJOG 118936–944(2011)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Jun, F. et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids: A randomized controlled trial and a meta-analysis of the literature. Arch. Gynecol. Obstet. 285, 1407–1413 (2012).Article

Jun,F.等人,《症状性子宫肌瘤的子宫动脉栓塞与手术:一项随机对照试验和文献荟萃分析》。拱门。妇科。障碍。2851407-1413(2012)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Stewart, E. A. et al. Uterine fibroids. Nat. Rev. Dis. Primers 2, 16043 (2016).Article

Stewart,E.A.等人。子宫肌瘤。国家牧师。《入门2》,16043(2016)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Anchan, R. M. et al. A comparative analysis of health-related quality of life 1 year following myomectomy or uterine artery embolization: Findings from the COMPARE-UF registry. J. Womens Health. 32, 423–433 (2023).Article

Anchan,R.M.等人。子宫肌瘤切除术或子宫动脉栓塞术后1年健康相关生活质量的比较分析:来自COMPARE-UF登记处的发现。J、 女性健康。32423-433(2023)。文章

Google Scholar

谷歌学者

Download referencesFundingThe study was supported by a special fund for research expense of Zhejiang University (Code: 226-2022-00093 and School code: K20220023).Author informationAuthor notesThese authors contributed equally: Junwen Peng and Jian Wang.Authors and AffiliationsDepartment of General Surgery, The First People’s Hospital of Jiande, Hangzhou, 311600, Zhejiang Province, ChinaJunwen Peng & Qianjun ShuDepartment of Vascular Surgery, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, 310009, Zhejiang Province, ChinaJian Wang, Yiting Luo, Siwei Wang & Zhenjie LiuAuthorsJunwen PengView author publicationsYou can also search for this author in.

下载参考文献资助该研究得到了浙江大学研究费用专项基金(代码:226-2022-00093和学校代码:K20220023)的支持。作者信息作者注意到这些作者做出了同样的贡献:彭俊文和王健。作者和所属单位浙江省杭州市建德市第一人民医院普外科,311600,浙江省杭州市,浙江大学医学院第二附属医院血管外科,浙江省杭州市,310009,浙江省杭州市,中国王健,罗怡婷,王思伟,刘振杰作者彭俊文观点作者出版物您也可以在中搜索这位作者。

PubMed Google ScholarJian WangView author publicationsYou can also search for this author in

PubMed Google ScholarJian WangView作者出版物您也可以在

PubMed Google ScholarQianjun ShuView author publicationsYou can also search for this author in

PubMed Google ScholarQianjun ShuView作者出版物您也可以在

PubMed Google ScholarYiting LuoView author publicationsYou can also search for this author in

PubMed Google ScholarYiting LuoView作者出版物您也可以在

PubMed Google ScholarSiwei WangView author publicationsYou can also search for this author in

PubMed Google ScholarSiwei WangView作者出版物您也可以在

PubMed Google ScholarZhenjie LiuView author publicationsYou can also search for this author in

PubMed谷歌学者刘振杰查看作者出版物您也可以在

PubMed Google ScholarContributionsJ.W.P., J.W., Z.J.L.: Conception and design. J.W., Z.J.L.: Analysis and interpretation. Q.J.S., Y.L., S.W.: Data collection. J.W.P., J.W.: Writing the article. J.W., J.W.P., Z.J.L.: Critical revision of the article. J.W., J.W.P., Q.J.S., Z.J.L., Y.L., S.W.: Final approval of the article.

PubMed谷歌学术贡献。W、 P.,J.W.,Z.J.L.:概念与设计。J、 W.,Z.J.L.:分析和解释。Q、 J.S.,Y.L.,S.W.:数据收集。J、 W.P.,J.W.:写这篇文章。J、 W.,J.W.P.,Z.J.L.:文章的关键修订。J、 W.,J.W.P.,Q.J.S.,Z.J.L.,Y.L.,S.W.:文章的最终批准。

J.W., Z.J.L.: Statistical analysis. J.W.P., J.W.: Obtained funding J.W.P., Overall responsibility.Corresponding authorCorrespondence to.

J、 W.,Z.J.L.:统计分析。J、 W.P.,J.W.:获得资金J.W.P.,全面负责。对应作者对应。

Zhenjie Liu.Ethics declarations

刘振杰。道德宣言

Competing interests

相互竞争的利益

The authors declare no competing interests.

Additional informationPublisher's noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Rights and permissions

Additional informationPublisher的noteSpringer Nature在已发布地图和机构隶属关系中的管辖权主张方面保持中立。权限和权限

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material.

开放获取本文是根据知识共享署名非商业性NoDerivatives 4.0国际许可证授权的,该许可证允许以任何媒介或格式进行任何非商业性使用,共享,分发和复制,只要您对原始作者和来源给予适当的信任,提供知识共享许可证的链接,并指出您是否修改了许可材料。

You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

根据本许可证,您无权共享源自本文或其部分的改编材料。本文中的图像或其他第三方材料包含在文章的知识共享许可证中,除非该材料的信用额度中另有说明。如果材料未包含在文章的知识共享许可证中,并且您的预期用途未被法律法规允许或超出允许的用途,则您需要直接获得版权所有者的许可。

To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/..

要查看此许可证的副本,请访问http://creativecommons.org/licenses/by-nc-nd/4.0/..

Reprints and permissionsAbout this articleCite this articlePeng, J., Wang, J., Shu, Q. et al. Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids.

转载和许可本文引用本文Peng,J.,Wang,J.,Shu,Q。等人。子宫动脉栓塞与肌瘤切除术治疗症状性子宫肌瘤的现有证据的系统评价和荟萃分析。

Sci Rep 14, 19252 (2024). https://doi.org/10.1038/s41598-024-69754-0Download citationReceived: 05 February 2024Accepted: 08 August 2024Published: 20 August 2024DOI: https://doi.org/10.1038/s41598-024-69754-0Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.

科学报告1419252(2024)。https://doi.org/10.1038/s41598-024-69754-0Download引文接收日期:2024年2月5日接受日期:2024年8月8日发布日期:2024年8月20日OI:https://doi.org/10.1038/s41598-024-69754-0Share本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。

Provided by the Springer Nature SharedIt content-sharing initiative

由Springer Nature SharedIt内容共享计划提供

KeywordsUterine artery embolizationMyomectomySymptomatic uterine fibroidsMeta-analysis

关键词子宫动脉栓塞肌瘤切除术症状性子宫肌瘤Meta分析

CommentsBy submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

。如果您发现有虐待行为或不符合我们的条款或准则,请将其标记为不合适。